Beximco Pharmaceuticals Limited Profit Margin

The latest profit margin for BXP.L is 16.04% as of March 2026. That compares with 13.99% in the prior-year period — up 14.6% year over year. That is above the sector sector average of 13.16%. Investors often review this figure alongside Beximco Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, BXP.L's profit margin moved from 13.99% to 16.04% — a 14.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Beximco Pharmaceuticals Limited's valuation or profitability profile.

Against its sector companies, BXP.L currently prints 16.04% for profit margin, while the sector average sits near 13.16%. That is roughly 21.8% above the sector mean. Large gaps often invite a closer look at Beximco Pharmaceuticals Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Beximco Pharmaceuticals Limited converts resources into returns. At 16.04%, BXP.L may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 13.99% in the prior-year period — up 14.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BXP.L's profit margin (16.04%), review year-over-year change from 13.99%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.